Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 13, Issue 8, Pages 1839-1843
Publisher
Informa UK Limited
Online
2017-06-08
DOI
10.1080/21645515.2017.1319026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
- (2015) Didier Riethmuller et al. BMC PUBLIC HEALTH
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
- (2015) Mona Saraiya et al. JNCI-Journal of the National Cancer Institute
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines
- (2015) Mona Saraiya et al. JNCI-Journal of the National Cancer Institute
- Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China)
- (2014) Beatriz Serrano et al. Cancer Epidemiology
- Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease
- (2014) E. A. Joura et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection
- (2014) Anna R. Giuliano et al. INTERNATIONAL JOURNAL OF CANCER
- Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
- (2012) Susanne Hartwig et al. BMC CANCER
- Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis
- (2012) Nicolas Van de Velde et al. JNCI-Journal of the National Cancer Institute
- Nucleic Acid Tests for the Detection of Alpha Human Papillomaviruses
- (2012) Mario Poljak et al. VACCINE
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
- (2010) Ni Li et al. INTERNATIONAL JOURNAL OF CANCER
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer
- (2008) Jean-Luc Prétet et al. GYNECOLOGIC ONCOLOGY
- Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array© using HPV52-specific TaqMan© E6/E7 quantitative real-time PCR
- (2008) Morgan Marks et al. JOURNAL OF VIROLOGICAL METHODS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started